Imperial Ginseng Products Ltd.
IGPFF
$0.0605
$0.010621.24%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | -82.76% | -80.83% | -96.25% | -82.37% | -73.44% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -82.76% | -80.83% | -97.48% | -97.41% | -59.38% |
Operating Income | 82.76% | 80.83% | 97.48% | 86.16% | -184.52% |
Income Before Tax | -170.26% | -72.22% | -92.41% | 85.33% | -95.65% |
Income Tax Expenses | -- | -120.70% | -100.00% | -- | -- |
Earnings from Continuing Operations | -170.26% | 48.44% | -90.14% | 84.91% | -94.34% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -170.26% | 48.44% | -90.14% | 84.91% | -94.34% |
EBIT | 82.76% | 80.83% | 97.48% | 86.16% | -184.52% |
EBITDA | -- | -- | 99.60% | 89.49% | -169.46% |
EPS Basic | -171.11% | 48.67% | -90.14% | 86.04% | -94.44% |
Normalized Basic EPS | -171.43% | 58.93% | 97.21% | 92.49% | -84.53% |
EPS Diluted | -171.11% | 51.01% | -90.37% | 86.04% | -94.44% |
Normalized Diluted EPS | -171.43% | 58.93% | 97.21% | 92.49% | -84.53% |
Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 7.60% | 2.25% |
Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 7.60% | 2.25% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |